| Autor: |
Carter JL; jennifer.carter@n-of-one.com., Elkin S; N-of-One Therapeutics, Inc., Lexington, MA, USA., Barton J; University of Maine Presque Isle-Houlton Center, Houlton, ME, USA. |
| Jazyk: |
angličtina |
| Zdroj: |
Personalized medicine [Per Med] 2011 May; Vol. 8 (3), pp. 311-315. |
| DOI: |
10.2217/pme.11.25 |
| Abstrakt: |
N-of-One is at the forefront of personalized medicine. The company's mission is to act as a bridge between the research community, diagnostic laboratories, the treating oncologist and the patient to develop customized cancer diagnostic and treatment strategies. N-of-One provides physicians and patients with relevant insight regarding molecular profiling technologies and facilitates rapid, high-quality testing of patient tissues. In addition to expanding treatment options, the services provided by N-of-One potentially provide cost savings by guiding patients and physicians toward more evidence-based, data-driven treatment approaches. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
